chr8-133060220-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000427060.6(SLA):c.61G>A(p.Val21Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000189 in 1,612,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000427060.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLA | NM_001045556.3 | c.-40-20G>A | intron_variant | ENST00000338087.10 | |||
TG | NM_003235.5 | c.7239+30197C>T | intron_variant | ENST00000220616.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TG | ENST00000220616.9 | c.7239+30197C>T | intron_variant | 1 | NM_003235.5 | P1 | |||
SLA | ENST00000338087.10 | c.-40-20G>A | intron_variant | 1 | NM_001045556.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000270 AC: 67AN: 247984Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 134274
GnomAD4 exome AF: 0.000196 AC: 286AN: 1460660Hom.: 0 Cov.: 31 AF XY: 0.000209 AC XY: 152AN XY: 726624
GnomAD4 genome AF: 0.000125 AC: 19AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 28, 2022 | The c.61G>A (p.V21I) alteration is located in exon 1 (coding exon 1) of the SLA gene. This alteration results from a G to A substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at